...
机译:2015年HCC异常政策变更后HCC和非HCC候选人的肝移植和候补人民死亡率
Johns Hopkins Univ Sch Med Dept Surg Baltimore MD 21205 USA;
Johns Hopkins Univ Sch Med Dept Surg Baltimore MD 21205 USA;
Johns Hopkins Univ Sch Med Dept Surg Baltimore MD 21205 USA;
Johns Hopkins Univ Sch Med Dept Surg Baltimore MD 21205 USA;
Johns Hopkins Univ Sch Med Dept Surg Baltimore MD 21205 USA;
Johns Hopkins Univ Sch Med Dept Surg Baltimore MD 21205 USA;
Johns Hopkins Univ Sch Med Dept Surg Baltimore MD 21205 USA;
Johns Hopkins Univ Sch Med Dept Surg Baltimore MD 21205 USA;
Johns Hopkins Univ Sch Med Dept Surg Baltimore MD 21205 USA;
Johns Hopkins Univ Sch Med Dept Surg Baltimore MD 21205 USA;
Johns Hopkins Univ Sch Med Dept Surg Baltimore MD 21205 USA;
Johns Hopkins Univ Sch Med Dept Surg Baltimore MD 21205 USA;
Johns Hopkins Bloomberg Sch Publ Hlth Dept Epidemiol Baltimore MD 21205 USA;
Johns Hopkins Univ Sch Med Dept Surg Baltimore MD 21205 USA;
cancer; malignancy; neoplasia; clinical research; practice; disparities; graft survival; liver disease: malignant; liver transplantation; hepatology; organ allocation;
机译:2015年HCC异常政策变更后HCC和非HCC候选者的肝移植和候补性死亡率
机译:肝移植竞赛:HCC和非HCC候选人之间的比较
机译:评估肝移植后次源供体特性对死亡率的影响:与非HCC患者进行HCC的时间依赖性分析
机译:根据SIOPEL研究的新结果-过去的经验和未来的观点,外科手术在儿童和青少年肝肿瘤肝母细胞瘤(HB)和肝细胞癌(HCC)处理中的作用不断变化,但仍在继续
机译:研究人类肝细胞癌(HCC)候选癌症疫苗。
机译:HCV根除与直接作用抗病毒药不会影响肝移植后的候诊肝癌进展或肝癌复发
机译:肝细胞癌(HCC)与非HCC:肝脏成像报告和数据系统的准确性和可靠性V2018